Seroepidemiology of group C rotavirus infection in England and Wales

European Journal of Epidemiology

Volumn 19, Issue 6, 2004, Pages 589-595

  Iturriza Gómara, Miren ^a,e   Clarke, Ian ^b   Desselberger, Ulrich ^d   Brown, David ^a   Thomas, Daniel ^c   Gray, Jim ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Serv Communic Dis Survlnc Centre   (United Kingdom)

^d CNRS   (France)

^e CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Group C rotavirus; Rural; Seroepidemiology; Urban

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ROTAVIRUS; SAMPLE; SEROEPIDEMIOLOGY; SEROPREVALENCE; SERUM; TIME SERIES ANALYSIS; UNITED KINGDOM; URBAN POPULATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES; WALES;

EID: 3442887950     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000032381.36658.cb     Document Type: Article

References (45)

1. Estes M. Rotaviruses and their replication In: Knipe DM, et al. (eds), Fields virology, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 1747-1785.
2. Kapikian A, Hoshino Y, Chanock R. Rotaviruses. In: Knipe D, et al. (eds), Fields virology, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 1787-1834.
3. Fang ZY, Ye Q, Ho MS, et al. Investigation of an outbreak of adult diarrhea rotavirus in China. J Infect Dis 1989; 160: 948-953.
4. Hung T, Chen GM, Wang CG, et al. Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet 1984; 1(8387): 1139-1142.
5. Krishnan T, Sen A, Choudhury JS, Das S, Naik TN, Bhattacharya SK. Emergence of adult diarrhoea rotavirus in Calcutta, India [letter]. Lancet 1999; 353: 380-381.
6. Peñaranda ME, Ho MS, Fang ZY, et al. Seroepidemiology of adult diarrhea rotavirus in China, 1977 to 1987. J Clin Microbiol 1989; 27: 2180-2183.
7. Chasey D, Bridger JC, McCrae MA. A new type of atypical rotavirus in pigs. Arch Virol 1986; 89: 235-423.
8. Otto P, Schulze P, Herbst W. Demonstration of group C rotaviruses in fecal samples of diarrheic dogs in Germany. Arch Virol 1999; 144: 2467-2473.
9. Adah MI, Wade A, Oseto M, Kuzuya M, Taniguchi K. Detection of human group C rotaviruses in Nigeria and sequence analysis of their genes encoding VP4, VP6, and VP7 proteins. J Med Virol 2002; 66: 269-275.
10. Castello AA, Argüelles MH, Villegas GA, et al. Characterization of human group C rotavirus in Argentina. J Med Virol 2000; 62: 199-200.
11. Castello AA, Argüelles MH, Villegas GA, Olthoff A, Glikmann G. Incidence and prevalence of human group C rotavirus infections in Argentina. J Med Virol 2002; 67: 106-112.
12. Caul EO, Ashley CR, Darville JM, Bridger JC. Group C rotavirus associated with fatal enteritis in a family outbreak. J Med Virol 1990; 30: 201-205.
13. James VL, Lambden PR, Caul EO, Clarke IN. Enzyme-linked immunosorbent assay based on recombinant human group C rotavirus inner capsid protein (VP6) to detect human group C rotaviruses in fecal samples. J Clin Microbiol 1998; 36: 3178-3181.
14. Jiang B, Dennehy PH, Spangenberger S, Gentsch JR, Glass RI. First detection of group C rotavirus in fecal specimens of children with diarrhea in the United States. J Infect Dis 1995; 172: 45-50.
15. Kuzuya M, Fujii R, Hamano M, et al. Survey of human group C rotaviruses in Japan during the winter of 1992 to 1993. J Clin Microbiol 1998; 36: 6-10.
16. Maunula L, Svensson L, von Bonsdorff CH. A family outbreak of gastroenteritis caused by group C rotavirus. Arch Virol 1992; 124: 269-278.
17. Morgan-Capner P, Wright J, Miller CL, Miller E. Surveillance of antibody to measles, mumps, and rubella by age. Brit Med J 1988; 297: 770-772.
18. Nilsson M, Sigstam G, Svensson L. Antibody prevalence and specificity to group C rotavirus in Swedish sera. J Med Virol 2000; 60: 210-215.
19. Oishi I, Yamazaki K, Minekawa Y. An occurrence of diarrheal cases associated with group C rotavirus in adults. Microbiol Immunol 1993; 37: 505-509.
20. Peñaranda ME, Cubitt WD, Sinarachatanant P, et al. Group C rotavirus infections in patients with diarrhea in Thailand, Nepal, and England. J Infect Dis 1989; 160: 392-397.
21. Rasool NB, Hamzah M, Jegathesan M, Wong YH, Qian Y, Green KY. Identification of a human group C rotavirus in Malaysia. J Med Virol 1994; 43: 209-211.
22. Rodger SM, Bishop RF, Holmes IH. Detection of a rotavirus-like agent associated with diarrhea in an infant. J Clin Microbiol 1982; 16: 724-726.
23. Von Bonsdorf CH, Svensson L. Human serogroup C rotavirus in Finland. Scand J Infect Dis 1988; 20: 475-478.
24. James VL, Lambden PR, Caul EO, Cooke SJ, Clarke IN. Seroepidemiology of human group C rotavirus in the UK. J Med Virol 1997; 52: 86-91.
25. Kuzuya M, Fujii R, Hamano M, Ohata R, Ogura H, Yamada M. Seroepidemiology of human group C rotavirus in Japan based on a blocking enzyme-linked immunosorbent assay. Clin Diag Lab Immunol 2001; 8: 161-165.
26. Nilsson M, Svenungsson B, Hedlund KO, et al. Incidence and genetic diversity of group C rotavirus among adults. J Infect Dis 2000; 182: 678-684.
27. Riepenhoff-Talty M, Morse K, Wang CH, et al. Epidemiology of group C rotavirus infection in Western New York women of childbearing age. J Clin Microbiol 1997; 35: 486-488.
28. Steele AD, James VL. Seroepidemiology of human group C rotavirus in South Africa. J Clin Microbiol 1999; 37: 4142-4144.
29. Eisen H, Siskind G. Variations in affinities of antibodies during immune response. Biochemistry 1964; 3: 996-1008.
30. Inouye S, Hasegawa A, Matsuno S, Katow S. Changes in antibody avidity after virus infections: Detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 1994; 20: 525-529.
31. Gray J. Avidity of EBV VGA-specific IgG antibodies: Distinction between recent primary infection, past infections and reactivation. J Virol Meth 1995; 52: 95-104.
32. Gray J, Cohen B, Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Meth 1993; 44: 11-24.
33. Gray J, Cunliffe C, Ball J, Graham D, Desselberger U, Estes M. Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by direct enzyme-linked immunosorbent assay with baculovirusexpressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol 1994; 32: 3059-3063.
34. Gray J, Wreghitt T. Immunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipients. Serodiag Immun Infect Dis 1989; 3: 389-393.
35. Ward K, Gray J, Fotheringham M, Sheldon M. IgG antibodies to human herpesvirus-6 in young children: Changes in avidity of antibody correlate with time after infection. J Med Virol 1993; 39: 131-138.
36. Ward K, Gray J, Joslin M, Sheldon M. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses. J Med Virol 1993; 39: 44-49.
37. Thomas DRH, Salmon RL, Kench SM, et al. Zoonotic illness: Determining risks and measuring effects: The association between current animal exposure and a history of illness in a well characterised rural population. J Epidemiol Commun Health 1994; 48: 151-155.
38. Bryant T. Confidence Interval Analysis 2.0. University of Southampton 2000. http://www.iss.soton.ac.uk/ software/swpage.php?id=526
39. Gray JJ, Jiang X, Capner PM, Desselberger U, Estes MK. Prevalence of antibodies to Norwalk virus in England: Detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol 1993; 31: 1022-1025.
40. Iturriza-Gómara M, Green J, Brown D, Ramsay M, Desselberger U, Gray J. Molecular epidemiology of human group A rotavirus infections in the UK between 1995 and 1998. J Clin Microbiol 2000; 38: 4094-4401.
41. Brokstad ICA, Cox RJ, Major D, Wood JM, Haaheim LR. Cross-reaction but no avidity change of serum antibody response after influenza vaccination. Vaccine 1995; 13: 1522-1528.
42. Fielding PA, Lambden PR, Caul EO, Clarke IN. Molecular characterization of the outer capsid spike protein (VP4) gene from human group C rotavirus. Virology 1994; 204: 442-446.
43. Grice AS, Lambden PR, Caul EO, Clarke IN. Sequence conservation of the major outer capsid glycoprotein of human group C rotaviruses. J Med Virol 1994; 44: 166-171.
44. Iturriza-Gómara M, Isherwood B, Desselberger U, Gray J. Reassortment in vivo: Driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol 2001; 75: 3696-3705.
45. Jiang B, Tsunemitsu H, Dennehy PH, et al. Sequence conservation and expression of the gene encoding the outer capsid glycoprotein among human group C rotaviruses of global distribution. Arch Virol 1996; 141: 381-390.